Disc Medicine (IRON) Other Working Capital Changes (2022 - 2026)
Disc Medicine (IRON) posted quarterly Other Working Capital Changes of -$174000.0 for Q2 2026, down 341.67% year-over-year from $72000.0 in Q2 2025, and down 3.57% quarter-over-quarter from -$168000.0 in Q1 2026.
Disc Medicine (IRON) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Disc Medicine (IRON) has reported Other Working Capital Changes for 5 consecutive years, with -$174000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Working Capital Changes fell 341.67% year-over-year to -$174000.0; the TTM figure through Jun 2026 stood at -$663000.0 (down 340.22% YoY), while the FY2025 annual figure was $186000.0, up 137.58% from the prior year.
- Other Working Capital Changes fell to -$174000.0 in Q2 2026 per IRON's latest filing, from -$168000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $7.2 million in Q1 2025 and bottomed at -$3.2 million in Q1 2022.
- Historically, Other Working Capital Changes has averaged $579388.9 across 5 years, with a median of -$192000.0 in 2022.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes plunged 476.47% — and 2025, when it surged 680.0%.
- Disc Medicine's Other Working Capital Changes stood at -$73000.0 in 2022, then surged by 146.58% to $34000.0 in 2023, then plunged by 423.53% to -$110000.0 in 2024, then slumped by 50.0% to -$165000.0 in 2025, then fell by 5.45% to -$174000.0 in 2026.
- Business Quant data shows IRON's Other Working Capital Changes at -$174000.0 in Q2 2026, -$168000.0 in Q1 2026, and -$165000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Disc Medicine | 3.02 Bn | 3.02 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -174,000.00 |
| Jun 30, 2026 | -174,000.00 |
| Jun 30, 2026 | -174,000.00 |
| Mar 31, 2026 | -168,000.00 |
| Mar 31, 2026 | -168,000.00 |
| Mar 31, 2026 | -168,000.00 |
| Dec 31, 2025 | -165,000.00 |
| Dec 31, 2025 | -165,000.00 |
| Dec 31, 2025 | -165,000.00 |
| Sep 30, 2025 | -156,000.00 |
| Sep 30, 2025 | -156,000.00 |
| Sep 30, 2025 | -156,000.00 |
| Jun 30, 2025 | 72,000.00 |
| Jun 30, 2025 | 72,000.00 |
| Jun 30, 2025 | 72,000.00 |
| Mar 31, 2025 | 435,000.00 |
| Mar 31, 2025 | 435,000.00 |
| Mar 31, 2025 | 435,000.00 |
| Dec 31, 2024 | -110,000.00 |
| Dec 31, 2024 | -110,000.00 |